Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
依洛尤单抗联合恩格列净治疗糖尿病的理论依据和设计:EXCEED-BHS3试验
期刊:Therapeutic Advances in Chronic Disease
影响因子:2.8
doi:10.1177/2040622320959248
Breder, Ikaro; Cunha Breder, Jessica; Bonilha, Isabella; Munhoz, Daniel B; Medorima, Sheila T Kimura; Oliveira, Daniela C; do Carmo, Helison R; Moreira, Camila; Kontush, Anatol; Zimetti, Francesca; Zanotti, Ilaria; Carvalho, Luiz Sergio F; Nadruz, Wilson; Muscelli, Elza; Quinaglia, Thiago; Sposito, Andrei C